First Bancorp (FBNC) Balance Sheet

The reported asset growth suggests the balance sheet is strengthening in aggregate, though the data does not separate organic loan growth from acquired balances, so the quality of that expansion cannot be fully confirmed. The swing in investment securities, which fell to about $1.9B in 2026Q2 before rising to $11.5B in 2026Q3, appears to reflect a reporting or classification change rather than a true portfolio shift, and investors should treat that line with caution. Equity grew from $1.4B to $1.7B over the same period, which may indicate retained earnings are building capital faster than the asset base.

The growth in liabilities tracks asset growth closely, which suggests the funding mix has not shifted dramatically toward wholesale sources, though the data alone cannot confirm deposit composition. The prior income statement findings flagged deposit cost pressure on net interest margin, and that concern is consistent with a franchise whose pricing power may be under strain. Investors should monitor deposit beta and non-interest-bearing mix in the 10-Q, as these would clarify whether the core funding base is as sticky as the rural footprint suggests.

A stable equity-to-assets level near 13% suggests the capital base has kept pace with balance sheet growth rather than being diluted by it. Return on equity, however, has fluctuated from 1.0% in 2025Q4 to 3.0% in 2026Q2 and 2026Q3, a range that points to earnings power still recovering and limits how much excess capital can be deployed confidently. Without regulatory ratios, the buffer available for buybacks or acquisitions cannot be quantified, so this conclusion should be treated as provisional.

The sharp provision spike in 2024Q3 followed by a substantial decline implies a period of elevated credit stress that has since eased, though NPL, charge-off, and coverage data are not supplied and the true credit trajectory cannot be fully verified. Provision levels near $1M per quarter in recent periods appear modest relative to a $13B balance sheet, which may indicate benign credit conditions or reserve releases that warrant investigation. Investors should examine reserve coverage and vertical concentration disclosures to determine whether current provisioning reflects durable credit quality.